Cargando…

Association between P2X7 Polymorphisms and Post-Transplant Outcomes in Allogeneic Haematopoietic Stem Cell Transplantation

Allogeneic stem cell transplantation (alloSCT) is a highly effective treatment method for haematologic malignancies. However, infection of acute organ dysfunction and graft versus host disease (GVHD) impact negatively on patient outcomes. Pre-transplant conditioning regimes are associated with high...

Descripción completa

Detalles Bibliográficos
Autores principales:	Koldej, Rachel M, Perera, Travis, Collins, Jenny, Ritchie, David S
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7312926/ https://www.ncbi.nlm.nih.gov/pubmed/32471261 http://dx.doi.org/10.3390/ijms21113772

Ejemplares similares

Clinical features, pathophysiology, and therapy of poor graft function post–allogeneic stem cell transplantation
por: Prabahran, Ashvind, et al.
Publicado: (2022)

P1312: CHARACTERISTICS OF MEMBRANOUS NEPHROPATHY AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Jin, Yue, et al.
Publicado: (2023)

Genomic prediction of relapse in recipients of allogeneic haematopoietic stem cell transplantation
por: Ritari, J., et al.
Publicado: (2018)

Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients
por: Davis, Joanne E., et al.
Publicado: (2021)

Immune recovery and the risk of CMV/ EBV reactivation in children post allogeneic haematopoietic stem cell transplantation
por: Janeczko, Małgorzata, et al.
Publicado: (2016)

Expanding the use of allogeneic haematopoietic cell transplantation in dermatology
por: Bauer, J.W.
Publicado: (2021)

Remission of Inflammatory Bowel Disease in Glucose-6-Phosphatase 3 Deficiency by Allogeneic Haematopoietic Stem Cell Transplantation
por: Bolton, Chrissy, et al.
Publicado: (2020)

Rehabilitation after Allogeneic Haematopoietic Stem Cell Transplantation: A Special Challenge
por: Bertz, Hartmut
Publicado: (2021)

Early-onset cardiac dysfunction following allogeneic haematopoietic stem cell transplantation
por: Moriyama, Shohei, et al.
Publicado: (2022)

Metabolic Profiling Early Post-Allogeneic Haematopoietic Cell Transplantation in the Context of CMV Infection
por: Rasmussen, Kirstine K., et al.
Publicado: (2023)

Voriconazole versus itraconazole for antifungal prophylaxis following allogeneic haematopoietic stem-cell transplantation
por: Marks, David I, et al.
Publicado: (2011)

Purinergic Signalling in Allogeneic Haematopoietic Stem Cell Transplantation and Graft-versus-Host Disease
por: Cuthbertson, Peter, et al.
Publicado: (2021)

Risk factors and clinical features for post-transplant thoracic air-leak syndrome in adult patients receiving allogeneic haematopoietic stem cell transplantation
por: Liu, Yao-Chung, et al.
Publicado: (2019)

Co-Infections with Cytomegalovirus and Human Herpesvirus Type 7 in Adult Polish Allogeneic Haematopoietic Stem Cell Transplant Recipients
por: Tomaszewska, Agnieszka, et al.
Publicado: (2013)

NOD2 Polymorphisms and Their Impact on Haematopoietic Stem Cell Transplant Outcome
por: Mayor, Neema P., et al.
Publicado: (2012)

The Role of MR Imaging in the Assessment of Clinical Outcomes in Children with X-Linked Adrenoleukodystrophy after Allogeneic Haematopoietic Stem Cell Transplantation
por: Bladowska, Joanna, et al.
Publicado: (2015)

Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience
por: Goździk, Jolanta, et al.
Publicado: (2011)

Infectious diseases in allogeneic haematopoietic stem cell transplantation: prevention and prophylaxis strategy guidelines 2016
por: Ullmann, Andrew J., et al.
Publicado: (2016)

Allogeneic haematopoietic stem cell transplantation from SARS-CoV-2 positive donors
por: Leclerc, Mathieu, et al.
Publicado: (2021)

Risk factors and outcomes of diffuse alveolar haemorrhage after allogeneic haematopoietic stem cell transplantation
por: Wu, Jin, et al.
Publicado: (2021)

Prognostic factors affecting the outcome after allogeneic haematopoietic stem cell transplantation for myelodysplastic syndrome
por: Belohlavkova, P, et al.
Publicado: (2021)

Impaired right ventricular function in long-term survivors of allogeneic haematopoietic stem-cell transplantation
por: Massey, Richard John, et al.
Publicado: (2021)

Editorial: Allogeneic haematopoietic stem cell transplantation for children with acute lymphoblastic leukaemia in the era of immunotherapy
por: Peters, Christina, et al.
Publicado: (2022)

The impact of donor type on resource utilisation and costs in allogeneic haematopoietic stem cell transplantation in the Netherlands
por: van Gorkom, Gwendolyn, et al.
Publicado: (2022)

Medication Adherence among Allogeneic Haematopoietic Stem Cell Transplant Recipients: A Systematic Review
por: Visintini, Chiara, et al.
Publicado: (2023)

P1277: IMPACT OF A NOVEL PROGNOSTIC MODEL ON ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION OUTCOMES IN PATIENTS WITH CMML
por: Zhou, Jian-Ying, et al.
Publicado: (2023)

Appropriate pre-transplant strategy for patients with myelodysplastic syndromes receiving allogeneic haematopoietic stem cell transplantation after myeloablative conditioning
por: Wang, Hong, et al.
Publicado: (2023)

Erratum to: Allogeneic Haematopoietic Stem Cell Transplantation as Therapy for Chronic Granulomatous Disease—Single Centre Experience
por: Goździk, Jolanta, et al.
Publicado: (2011)

Lymph node tuberculosis after allogeneic haematopoietic stem cell transplantation: an atypical presentation of an uncommon complication
por: Martín-Sánchez, Guillermo, et al.
Publicado: (2015)

Long-term outcome following cyclosporine-related neurotoxicity in paediatric allogeneic haematopoietic stem cell transplantation
por: Straathof, K, et al.
Publicado: (2017)

Refractory autoimmune haemolytic anaemia following allogenic haematopoietic stem cell transplantation: successful treatment of rituximab
por: Li, Xiaofan, et al.
Publicado: (2019)

Immunogenicity of the inactivated influenza vaccine in children who have undergone allogeneic haematopoietic stem cell transplant
por: Ryan, Anne L., et al.
Publicado: (2019)

Cerebellar Neurocysticercosis as Long-Term Complication of Allogeneic Haematopoietic Stem Cell Transplantation from Haploidentical Donor
por: Meconi, Federico, et al.
Publicado: (2019)

Complicated and persistent severe COVID-19 pneumonia in a recipient of allogeneic haematopoietic stem cell transplant
por: Lazzari, Lorenzo, et al.
Publicado: (2021)

Wharton’s jelly‐derived stromal cells and their cell therapy applications in allogeneic haematopoietic stem cell transplantation
por: Pochon, Cécile, et al.
Publicado: (2022)

Allogeneic haematopoietic stem cell transplantation resets T‐ and B‐cell compartments in sickle cell disease patients
por: Jarduli‐Maciel, Luciana Ribeiro, et al.
Publicado: (2022)

Role of allogeneic haematopoietic stem cell transplantation in the treatment of adult acute lymphoblastic leukaemia in the era of immunotherapy
por: Sun, Wei, et al.
Publicado: (2022)

Outcomes of allogeneic haematopoietic stem cell transplantation for paediatric patients with MLL-rearranged acute myeloid leukaemia
por: Bai, Lu, et al.
Publicado: (2022)

Medication adherence among allogeneic haematopoietic stem cell transplant recipients: a systematic review protocol
por: Visintini, Chiara, et al.
Publicado: (2022)

PB2409: CLINICAL PROGNOSTIC MODEL OF LIVER FAILURE AFTER ALLOGENEIC HAEMATOPOIETIC STEM CELL TRANSPLANTATION
por: Qu, Qingyuan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_svm2jle4e75ik963v5cf5alkr2